Skip to main content
FinSpry Logo
FinSpry
PBH logo
PBH
(NYSE)
Prestige Consumer Healthcare Inc.
$52.48-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Prestige Consumer Healthcare (PBH) Stock Price & Financial Analysis

Prestige Consumer Healthcare Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$51.28 - $57.34
52-Week High$89.37
52-Week Low$57.25
Open$56.94
Volume1.59M
Average Volume (3M)1.59M
Market Cap2.52B
Shares Outstanding48.09M
P/E Ratio (TTM)14.87
Forward P/E17.06
Price to Sales (P/S)2.51
Price to Book (P/B)1.52
EV/EBITDA11.09
Revenue (TTM)1.10B
Net Income (TTM)186.50M
Free Cash Flow (TTM)267.19M
EPS (TTM)$3.88
Profit Margin16.90%
Operating Margin30.34%
Return on Equity (ROE)10.19%
Debt to Equity0.57
50-Day MA$64.96
200-Day MA$66.08
52-Week Change-32.72%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateSep 27, 2018

Frequently Asked Questions About Prestige Consumer Healthcare

What is the current stock price for PBH?

As of the latest trading session, PBH stock trades at $52.48. The 52-week range is $57.25–$89.37, with a day range of $51.28–$57.34.

What is the P/E ratio for PBH?

Prestige Consumer Healthcare's trailing P/E ratio is 14.9, meaning investors pay $14.9 for every $1 of annual earnings. The forward P/E is 17.1, reflecting analyst expectations for future earnings. Prestige Consumer Healthcare operates in the Healthcare sector.

Does PBH pay dividends?

Prestige Consumer Healthcare does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PBH?

Based on 1 analyst, the consensus for PBH is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PBH?

Prestige Consumer Healthcare's market capitalization is $2.52B, classifying it as a mid-cap company. Prestige Consumer Healthcare operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.